VITA 34 AG (V3V.DE)
EUR 4.28
(2.88%)
EUR 4.28
(2.88%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 135.58 Million EUR | -0.06% |
| 2022 | 135.65 Million EUR | -0.26% |
| 2021 | 136 Million EUR | 370.13% |
| 2020 | 28.92 Million EUR | -6.17% |
| 2019 | 30.83 Million EUR | 3.56% |
| 2018 | 29.77 Million EUR | -7.88% |
| 2017 | 32.31 Million EUR | 63.45% |
| 2016 | 19.77 Million EUR | -1.26% |
| 2015 | 20.02 Million EUR | 34.44% |
| 2014 | 14.89 Million EUR | 3.91% |
| 2013 | 14.33 Million EUR | -11.14% |
| 2012 | 16.13 Million EUR | 9.52% |
| 2011 | 14.73 Million EUR | -17.56% |
| 2010 | 17.87 Million EUR | 45.56% |
| 2009 | 12.27 Million EUR | 0.61% |
| 2008 | 12.2 Million EUR | -2.61% |
| 2007 | 12.53 Million EUR | -2.68% |
| 2006 | 12.87 Million EUR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 134.89 Million EUR | 2.36% |
| 2024 Q1 | 132.45 Million EUR | -2.31% |
| 2023 Q2 | 141.53 Million EUR | 2.73% |
| 2023 Q1 | 137.77 Million EUR | 1.56% |
| 2023 Q4 | 135.58 Million EUR | -1.87% |
| 2023 Q3 | 138.16 Million EUR | -2.38% |
| 2023 FY | 135.58 Million EUR | -0.06% |
| 2022 Q3 | 137.75 Million EUR | 0.0% |
| 2022 Q1 | 136.11 Million EUR | 0.08% |
| 2022 FY | 135.65 Million EUR | -0.26% |
| 2022 Q2 | 137.74 Million EUR | 1.2% |
| 2022 Q4 | 135.65 Million EUR | -1.52% |
| 2021 Q3 | 28.19 Million EUR | -5.12% |
| 2021 Q4 | 136 Million EUR | 382.36% |
| 2021 FY | 136 Million EUR | 370.13% |
| 2021 Q1 | 29.44 Million EUR | 1.77% |
| 2021 Q2 | 29.71 Million EUR | 0.94% |
| 2020 FY | 28.92 Million EUR | -6.17% |
| 2020 Q1 | 30.25 Million EUR | -1.88% |
| 2020 Q4 | 28.92 Million EUR | -1.3% |
| 2020 Q3 | 29.31 Million EUR | -1.74% |
| 2020 Q2 | 29.82 Million EUR | -1.4% |
| 2019 Q1 | 30.57 Million EUR | 2.7% |
| 2019 FY | 30.83 Million EUR | 3.56% |
| 2019 Q3 | 29.97 Million EUR | -0.59% |
| 2019 Q2 | 30.15 Million EUR | -1.37% |
| 2019 Q4 | 30.83 Million EUR | 2.86% |
| 2018 Q4 | 29.77 Million EUR | -4.64% |
| 2018 Q3 | 31.21 Million EUR | 0.7% |
| 2018 Q2 | 31 Million EUR | -3.49% |
| 2018 Q1 | 32.12 Million EUR | -0.61% |
| 2018 FY | 29.77 Million EUR | -7.88% |
| 2017 Q1 | 19.48 Million EUR | -1.45% |
| 2017 Q4 | 32.31 Million EUR | -18.92% |
| 2017 Q3 | 39.86 Million EUR | -1.37% |
| 2017 Q2 | 40.41 Million EUR | 107.39% |
| 2017 FY | 32.31 Million EUR | 63.45% |
| 2016 Q2 | 19.26 Million EUR | -2.84% |
| 2016 Q4 | 19.77 Million EUR | -0.48% |
| 2016 FY | 19.77 Million EUR | -1.26% |
| 2016 Q3 | 19.86 Million EUR | 3.16% |
| 2016 Q1 | 19.82 Million EUR | -1.0% |
| 2015 Q1 | 15.57 Million EUR | 4.56% |
| 2015 Q2 | 15.78 Million EUR | 1.32% |
| 2015 Q3 | 20.59 Million EUR | 30.49% |
| 2015 Q4 | 20.02 Million EUR | -2.75% |
| 2015 FY | 20.02 Million EUR | 34.44% |
| 2014 Q2 | 13.96 Million EUR | -0.87% |
| 2014 Q3 | 14.91 Million EUR | 6.78% |
| 2014 Q4 | 14.89 Million EUR | -0.11% |
| 2014 Q1 | 14.08 Million EUR | -1.72% |
| 2014 FY | 14.89 Million EUR | 3.91% |
| 2013 Q4 | 14.33 Million EUR | 0.06% |
| 2013 FY | 14.33 Million EUR | -11.14% |
| 2013 Q1 | 14.95 Million EUR | -7.31% |
| 2013 Q2 | 14.47 Million EUR | -3.2% |
| 2013 Q3 | 14.32 Million EUR | -1.04% |
| 2012 Q2 | 14.71 Million EUR | 4.32% |
| 2012 Q1 | 14.1 Million EUR | -4.23% |
| 2012 Q3 | 15.61 Million EUR | 6.12% |
| 2012 FY | 16.13 Million EUR | 9.52% |
| 2012 Q4 | 16.13 Million EUR | 3.3% |
| 2011 Q2 | 15.18 Million EUR | 1.54% |
| 2011 Q1 | 14.95 Million EUR | -16.3% |
| 2011 Q4 | 14.73 Million EUR | 3.48% |
| 2011 FY | 14.73 Million EUR | -17.56% |
| 2011 Q3 | 14.23 Million EUR | -6.26% |
| 2010 Q4 | 17.87 Million EUR | -1.94% |
| 2010 Q1 | 10.86 Million EUR | -11.49% |
| 2010 FY | 17.87 Million EUR | 45.56% |
| 2010 Q2 | 17.82 Million EUR | 64.02% |
| 2010 Q3 | 18.22 Million EUR | 2.26% |
| 2009 Q2 | 11.42 Million EUR | 0.0% |
| 2009 Q4 | 12.27 Million EUR | 0.0% |
| 2009 FY | 12.27 Million EUR | 0.61% |
| 2008 FY | 12.2 Million EUR | -2.61% |
| 2007 FY | 12.53 Million EUR | -2.68% |
| 2006 FY | 12.87 Million EUR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Fresenius Medical Care AG & Co. KGaA | 19.1 Billion EUR | 99.29% |
| Fresenius SE & Co. KGaA | 25.63 Billion EUR | 99.471% |
| LIMES Schlosskliniken AG | 16.6 Million EUR | -716.48% |
| M1 Kliniken AG | 69.72 Million EUR | -94.439% |
| Maternus-Kliniken Aktiengesellschaft | 206.49 Million EUR | 34.341% |
| MEDICLIN Aktiengesellschaft | 742.57 Million EUR | 81.742% |
| RHÖN-KLINIKUM Aktiengesellschaft | 499.09 Million EUR | 72.835% |